| Literature DB >> 33363150 |
Sarah Delbaere1, Adelbert De Clercq1, Shuji Mizumoto2, Fredrik Noborn3,4, Jan Willem Bek1, Lien Alluyn1, Charlotte Gistelinck5, Delfien Syx1, Phil L Salmon6, Paul J Coucke1, Göran Larson3,4, Shuhei Yamada2, Andy Willaert1, Fransiska Malfait1.
Abstract
Proteoglycans are structurally and functionally diverse biomacromolecules found abundantly on cell membranes and in the extracellular matrix. They consist of a core protein linked to glycosaminoglycan chains via a tetrasaccharide linkage region. Here, we show that CRISPR/Cas9-mediated b3galt6 knock-out zebrafish, lacking galactosyltransferase II, which adds the third sugar in the linkage region, largely recapitulate the phenotypic abnormalities seen in human β3GalT6-deficiency disorders. These comprise craniofacial dysmorphism, generalized skeletal dysplasia, skin involvement and indications for muscle hypotonia. In-depth TEM analysis revealed disturbed collagen fibril organization as the most consistent ultrastructural characteristic throughout different affected tissues. Strikingly, despite a strong reduction in glycosaminoglycan content, as demonstrated by anion-exchange HPLC, subsequent LC-MS/MS analysis revealed a small amount of proteoglycans containing a unique linkage region consisting of only three sugars. This implies that formation of glycosaminoglycans with an immature linkage region is possible in a pathogenic context. Our study, therefore unveils a novel rescue mechanism for proteoglycan production in the absence of galactosyltransferase II, hereby opening new avenues for therapeutic intervention.Entities:
Keywords: b3galt6; linkeropathies; proteoglycans; trisaccharide linkage region; zebrafish
Year: 2020 PMID: 33363150 PMCID: PMC7758351 DOI: 10.3389/fcell.2020.597857
Source DB: PubMed Journal: Front Cell Dev Biol ISSN: 2296-634X